Peter J. Graham - 30 Jun 2026 Form 4 Insider Report for ADC Therapeutics SA (ADCT)

Reporting relationship: Chief Legal Officer
Issuer ticker: ADCT
Reported as of: 30 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Jul 2026, 17:16:41 UTC
Prior SEC filing: 18 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Lisa Kallebo, Attorney-in-Fact for Peter Graham

Key filing fact

Peter J. Graham filed Form 4 for ADC Therapeutics SA (ADCT) on 02 Jul 2026.

Key facts

This page summarizes Peter J. Graham's Form 4 filing for ADC Therapeutics SA (ADCT).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 02 Jul 2026, 17:16.

Change

Previous filing in this sequence was filed on 18 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001235635 Primary reporting owner

GRAHAM PETER J

Relationship: Chief Legal Officer
Address: 430 MOUNTAIN AVENUE, SUITE 404, NEW PROVIDENCE
Signature: /s/ Lisa Kallebo, Attorney-in-Fact for Peter Graham
Signature date: 02 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ADCT transaction

Common Shares

Award

Transaction value
Shares: +221,100
Change %: +36%
Price: $0.000000^*
Shares after: 841,640
Date: 30 Jun 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents an award of restricted stock units ("RSUs") granted on June 30, 2026 pursuant to an incentive award letter agreement. The RSUs will vest upon the earlier of (i) June 30, 2027 or (ii) termination of employment by the Issuer without cause or by the reporting person for good reason, subject to the reporting person's continued employment with the Issuer on the vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock.